Abpro Holdings Inc Share Price

NASDAQ: ABP

Large Cap

$0.20

+0.01

(+7.66%)

as on September 18, 2025 at 1:29 am IST

$₹

Abpro Holdings Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
$0.18
Day's Price Range
$0.2
$0.2
10.00%
Downside
52 Week's Low
52 Week's High
$0.15
52-Week Price Range
$8.8
$0.2
24.20%
Downside
4300.00%
Upside

Abpro Holdings Inc share price movements today

Previous Close: $0.18
Open: $0.18
Volume: 4.3M
Day's Low - High: $0.18 - $0.2
52 Week Low - High: $0.15 - $8.8

Abpro Holdings Inc Historical Returns

1 Month Return: -31.62 %
3 Month Return: -17.32 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Abpro Holdings Inc Stock Fundamentals & Key Indicators

Check Abpro Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.6M

EPS (TTM)

-0.16

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

31215100.00%

Abpro Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abpro Holdings Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Abpro Holdings Inc	NA	$14.6M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Abpro Holdings Inc Stock's Interest Amongst Investors

Search interest for Abpro Holdings Inc Stock has decreased by -68% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-68% versus previous 30 day period

Abpro Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	0	-	-	-	0	-	-
Gross Profit	-1	-1	2	0	0	0	1	0	-	-
Operating Income	-2	-2	-2	-10	-2	-2	-1	-7	-2	-2
EBITDA	-2	-2	-2	-10	0	-2	0	-5	-2	-2
Interest Expense	-	-	0	0	0	0	-	0	0	0
Depreciation	-	-	-	-	0	0	-	-	0	0
Income Before Tax	-2	-2	0	-15	0	-2	-2	-5	-3	-2
Income Tax Expense	-	-	0	-1	-	-	0	0	-	-
Net Income	-2	-2	0	-14	0	-2	0	-5	-3	-2
Net Profit Margin	-10844.00%	-10844.00%	-178.52%	-11913.93%	0.00%	0.00%	0.00%	-3010.38%	0.00%	0.00%

Abpro Holdings Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	1	2	0	2	0	0
Gross Profit	0	0	-8	-7	0	0
Operating Income	5	-12	-14	-16	-11	-9
EBITDA	-5	-12	-14	-15	-10	-6
Interest Expense	0	-	-	0	0	0
Depreciation	-	-	-	0	0	0
Income Before Tax	-6	-12	-14	-16	-11	-7
Income Tax Expense	0	0	-	0	-	-
Net Income	-5	-12	-14	-17	-11	-7
Net Profit Margin	-327.24%	-561.43%	-3069.79%	-848.45%	-9595.08%	-3951.91%

Abpro Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-2	8	-14	0	0	0	-5	-3	-2
Operating Cash Flow	-1	-1	-5	-2	-1	3	-8	-1	-1
Investing Cash Flow	0	278	-278	-	-	29	-29	-	-
Financing Cash Flow	0	0	277	2	1	0	40	0	2
Change in Cash	3	-1	0	0	0	0	2	-1	0

Abpro Holdings Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-12	-14	-17	-11	-7
Operating Cash Flow	-9	-10	-8	-7	-9
Investing Cash Flow	0	0	0	0	-
Financing Cash Flow	17	0	9	0	11
Change in Cash	7	6	0	-6	2

Insights on Abpro Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, ABP stock has moved up by 11.7%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 167.3%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 214.7%

About Abpro Holdings Inc

Abpro Holdings, Inc. is a biotechnology company. The Company is advancing a pipeline of next generation antibody therapies for human epidermal growth factor receptor 2 (HER2)+cancers, non-HER2+ gastric and liver cancer, and wet age-related macular degeneration and diabetic macular edema. These antibodies are developed using the Company’s proprietary DiversImmune platform. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting HER2, and CD3, T-cell co-receptor. ABP-201 is designed to block blood vessel formation and normalize damaged vessels through co-targeting VEGF and ANG-2. It plans to develop ABP-201 to treat vascular disease of the eye, focusing on wet age-related macular degeneration (Wet AMD).

Organisation	Abpro Holdings Inc
Headquarters	68 Cummings Park Drive, Woburn, MA, United States, 01801
CEO	Mr. Jin Wook Suk
E-voting on shares	Click here to vote

Key Management of Abpro Holdings Inc

Name	Title
Mr. Jin Wook Suk	CEO & Chairman of the Board
Dr. Robert J. Markelewicz Jr., M.D.	Chief Medical Officer
Mr. Eugene Y. Chan M.D.	Co-Founder

FAQs

What is Abpro Holdings Inc share price today?

Abpro Holdings Inc share price today is $0.2 as on September 18, 2025 at 1:29 am IST at the close of the market. Abpro Holdings Inc share today touched a day high of $0.2 and a low of $0.18.

What is the 52 week high and 52 week low for Abpro Holdings Inc share?

Abpro Holdings Inc share touched a 52 week high of $8.8 on November 14, 2024 and a 52 week low of $0.15 on May 14, 2025. Abpro Holdings Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $0.2,which is 97.73% down from its 52 week high and 31.93% up from its 52 week low.

What is Abpro Holdings Inc's market capitalisation today?

Abpro Holdings Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Abpro Holdings Inc Stock (ABP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Abpro Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abpro Holdings Inc Shares that will get you 7.5000 shares as per Abpro Holdings Inc share price of $0.2 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Abpro Holdings Inc Stock (ABP) from India?

Indian investors can start investing in Abpro Holdings Inc (ABP) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 10:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Abpro Holdings Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 10:43 am IST). Based on Abpro Holdings Inc share’s latest price of $0.2 as on September 18, 2025 at 1:29 am IST, you will get 50.0000 shares of Abpro Holdings Inc. Learn more about fractional shares .